intloko_bn_img
Umfanekiso okhoyo

I-Anti-CCP

I-Anti-cyclic Citrullinated Peptide Antibody

I-Rheumatoid arthritis (RA) yeyona nto ixhaphakileyo yokukrala kwamathambo kwihlabathi jikelele.Sisifo esinganyangekiyo, esintsonkothileyo, kwaye esisisifo esiziintsholongwane esizilawulayo (i-AD).

Ukuchongwa kwe-RA ekubonisweni kokuqala kunye nonyango kwisigaba sangaphambili kunokuchaphazela ikhosi yesifo, ukuthintela ukuphuhliswa kokhukuliseko oluhlangeneyo okanye ukulibazisa ukuqhubela phambili kwesifo esiqhekezayo.Ukuxilongwa kwangoko kunye nonyango kunokuchaphazela iziphumo zesifo nakwimeko yoxolelo.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Iimpawu zoMsebenzi

Uluhlu lomgca:10-500U/mL;

Ukuchaneka okuphezulu: CV≤15%;

Iziphumo ezithembekileyo: zihambelana nomgangatho wamazwe ngamazwe;

Uvavanyo olukhawulezayo: I-15 min ifumana iziphumo

Ukuchaneka: ukutenxa okunxulumene neziphumo zokulinganisa akuyi kudlula ± 15% xa isilinganisi sokuchaneka esilungiswe ngumgangatho wesizwe we-Anti-CCP okanye isilinganisi sokuchaneka esisemgangathweni sivavanywa.

Ugcino Nozinzo

1. Gcina i-detector buffer ku-2～30℃.Isithinteli sizinzile ukuya kwiinyanga ezili-18.

2. Gcina i-Aehealth Anti-CCP Rapid Quantitative test cassette kwi-2～30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.

3. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.

  • Ngaphambili:
  • Okulandelayo:
    • Ukubuza